Loading…
Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use
Laboratory-based respiratory pathogen (RP) results are often available too late to influence clinical decisions such as hospitalisation or antibiotic treatment due to time delay in transport of specimens and testing schedules. Ward-based i.e. point of care (POC) testing providing rapid results may a...
Saved in:
Published in: | BMC infectious diseases 2017-10, Vol.17 (1), p.671-671, Article 671 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c493t-7307f64b2d49de0e6fefef2c6020ba04889d2af7529381291ddd2f0f29d12df43 |
---|---|
cites | cdi_FETCH-LOGICAL-c493t-7307f64b2d49de0e6fefef2c6020ba04889d2af7529381291ddd2f0f29d12df43 |
container_end_page | 671 |
container_issue | 1 |
container_start_page | 671 |
container_title | BMC infectious diseases |
container_volume | 17 |
creator | Andrews, Denise Chetty, Yumela Cooper, Ben S Virk, Manjinder Glass, Stephen K Letters, Andrew Kelly, Philip A Sudhanva, Malur Jeyaratnam, Dakshika |
description | Laboratory-based respiratory pathogen (RP) results are often available too late to influence clinical decisions such as hospitalisation or antibiotic treatment due to time delay in transport of specimens and testing schedules. Ward-based i.e. point of care (POC) testing providing rapid results may alter the clinical management pathway.
FilmArray® RP polymerase chain reaction (PCR) systems were placed in three in-patient and out-patient medical areas. Patients presenting with influenza-like illness /upper respiratory tract infection +/- lower RTI were recruited between January-July 2015. FilmArray® POC testing occurred on even days of the month (intervention) or routine, laboratory-based RP PCR testing +/- atypical serology on odd days (control). The primary outcome was length of hospital stay. The secondary outcomes were impact on the use of antimicrobials, readmissions, all-cause mortality, length of ward stay and turn-around time (TAT) (time to result from admission).
Of 606 eligible patients, 545 (89.9%) were included; 211 in the control arm and 334 in the intervention arm. 20% of control arm patients and 24% of intervention arm patients had an RP detected. POC testing was not associated with the primary outcome measure, length of stay, but reduced the TAT from 39.5 h to 19.0 h, p |
doi_str_mv | 10.1186/s12879-017-2784-z |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_58351e6a883f41ac98f8ec9ae067881b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_58351e6a883f41ac98f8ec9ae067881b</doaj_id><sourcerecordid>1950174612</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-7307f64b2d49de0e6fefef2c6020ba04889d2af7529381291ddd2f0f29d12df43</originalsourceid><addsrcrecordid>eNpdks1u1TAQhSMEoqXwAGyQJTYsCMTOn8OiErrip1IRCMHamsTje10lcWo7hdtn5WGYNOWqRZEVOznnG3t8kuQ5z95wLqu3gQtZN2nG61TUskivHyTHvKh5KvK8eHhnfpQ8CeEiI6EUzePkSDQ0LUp-nPz5MvfRTj3-Zt8239nk7BiZM6wDjyxiiHbcsiv0YQ7Mu5mW-Jr10DoP0fl92kJAfRDakcUd-TxCHHAlgaYKgf2yccc8hsmuThJBF8lhsIvWjeEdA3Y5Q7Cph1G7wS7gEGe9ZxAChnBTYJgWlxtZj-OWiFQgRCDJqGlEO9jOu9ZCz-aAT5NHBvqAz27fJ8nPjx9-bD6n518_nW3en6dd0eQxrfOsNlXRCl00GjOsDNIjuioTWQtZIWWjBZi6FE0uuWi41lqYzIhGc6FNkZ8kZytXO7hQk7cD-L1yYNXNB-e3Cny0XY-qlHnJsQIpc1Nw6BppJHYNYFbVUvKWWKcra5rbAXVHXfTQ34Pe_zPandq6K1VWeUnHIcCrW4B3lzNdjKJWdtj3MKKbg-JNuVx-xQVJX_4nvXCzH6lVi0qWNWWnJBVfVdTZEDyaw2Z4ppYcqjWHirBqyaG6Js-Lu6c4OP4FL_8L-dDgIg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1958572335</pqid></control><display><type>article</type><title>Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Andrews, Denise ; Chetty, Yumela ; Cooper, Ben S ; Virk, Manjinder ; Glass, Stephen K ; Letters, Andrew ; Kelly, Philip A ; Sudhanva, Malur ; Jeyaratnam, Dakshika</creator><creatorcontrib>Andrews, Denise ; Chetty, Yumela ; Cooper, Ben S ; Virk, Manjinder ; Glass, Stephen K ; Letters, Andrew ; Kelly, Philip A ; Sudhanva, Malur ; Jeyaratnam, Dakshika</creatorcontrib><description>Laboratory-based respiratory pathogen (RP) results are often available too late to influence clinical decisions such as hospitalisation or antibiotic treatment due to time delay in transport of specimens and testing schedules. Ward-based i.e. point of care (POC) testing providing rapid results may alter the clinical management pathway.
FilmArray® RP polymerase chain reaction (PCR) systems were placed in three in-patient and out-patient medical areas. Patients presenting with influenza-like illness /upper respiratory tract infection +/- lower RTI were recruited between January-July 2015. FilmArray® POC testing occurred on even days of the month (intervention) or routine, laboratory-based RP PCR testing +/- atypical serology on odd days (control). The primary outcome was length of hospital stay. The secondary outcomes were impact on the use of antimicrobials, readmissions, all-cause mortality, length of ward stay and turn-around time (TAT) (time to result from admission).
Of 606 eligible patients, 545 (89.9%) were included; 211 in the control arm and 334 in the intervention arm. 20% of control arm patients and 24% of intervention arm patients had an RP detected. POC testing was not associated with the primary outcome measure, length of stay, but reduced the TAT from 39.5 h to 19.0 h, p < 0.001. Only the prescribing decision differed between study arms, p < 0.001. When antivirals were given, the intervention was associated with a reduction in the median time to the first dose of 36 h and allowed appropriate treatment of mycoplasma infection.
We found no association between respiratory PCR POC testing and length of stay or most of the secondary outcomes except the antimicrobial prescribing decision. This was probably due to a delay in initiating FilmArray® testing. Despite this, POC testing allowed time-critical antivirals to be given significantly faster, appropriate mycoplasma treatment and results were available considerably faster than routine, laboratory-based testing. Ward-staff of all grades performed POC testing without difficulty suggesting potential use across many divergent healthcare settings. Further studies evaluating the implementation of rapid respiratory PCR POC testing and the effect on length of stay and antimicrobial use are required.
ISRCTN10470967 , Retrospectively Registered, 30/6/2015.</description><identifier>ISSN: 1471-2334</identifier><identifier>EISSN: 1471-2334</identifier><identifier>DOI: 10.1186/s12879-017-2784-z</identifier><identifier>PMID: 29017451</identifier><language>eng</language><publisher>England: BioMed Central</publisher><subject>Adults ; Aged ; Anti-Infective Agents - therapeutic use ; Antibiotics ; Antimicrobial agents ; Bacterial infections ; Chlamydia ; Chlamydia pneumoniae ; Clinical outcomes ; Emergency medical care ; Epidemics ; Female ; FilmArray ; Holidays & special occasions ; Hospital costs ; Hospitalization ; Humans ; Illnesses ; Infections ; Infectious diseases ; Influenza ; Influenza, Human - genetics ; Length of stay ; Length of Stay - statistics & numerical data ; Male ; Middle Aged ; Multiplex Polymerase Chain Reaction - methods ; Multiplexing ; Mycoplasma pneumoniae ; Patients ; Pneumonia ; Point of care ; Point-of-Care Testing - statistics & numerical data ; Point-of-Care Testing - utilization ; Respiratory pathogens ; Respiratory syncytial virus ; Respiratory tract ; Respiratory tract diseases ; Respiratory tract infection ; Respiratory Tract Infections - drug therapy ; Respiratory Tract Infections - microbiology ; Respiratory viruses ; Retrospective Studies ; Testing laboratories ; Viruses</subject><ispartof>BMC infectious diseases, 2017-10, Vol.17 (1), p.671-671, Article 671</ispartof><rights>Copyright BioMed Central 2017</rights><rights>The Author(s). 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-7307f64b2d49de0e6fefef2c6020ba04889d2af7529381291ddd2f0f29d12df43</citedby><cites>FETCH-LOGICAL-c493t-7307f64b2d49de0e6fefef2c6020ba04889d2af7529381291ddd2f0f29d12df43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635493/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1958572335?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,38493,43871,44566,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29017451$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Andrews, Denise</creatorcontrib><creatorcontrib>Chetty, Yumela</creatorcontrib><creatorcontrib>Cooper, Ben S</creatorcontrib><creatorcontrib>Virk, Manjinder</creatorcontrib><creatorcontrib>Glass, Stephen K</creatorcontrib><creatorcontrib>Letters, Andrew</creatorcontrib><creatorcontrib>Kelly, Philip A</creatorcontrib><creatorcontrib>Sudhanva, Malur</creatorcontrib><creatorcontrib>Jeyaratnam, Dakshika</creatorcontrib><title>Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use</title><title>BMC infectious diseases</title><addtitle>BMC Infect Dis</addtitle><description>Laboratory-based respiratory pathogen (RP) results are often available too late to influence clinical decisions such as hospitalisation or antibiotic treatment due to time delay in transport of specimens and testing schedules. Ward-based i.e. point of care (POC) testing providing rapid results may alter the clinical management pathway.
FilmArray® RP polymerase chain reaction (PCR) systems were placed in three in-patient and out-patient medical areas. Patients presenting with influenza-like illness /upper respiratory tract infection +/- lower RTI were recruited between January-July 2015. FilmArray® POC testing occurred on even days of the month (intervention) or routine, laboratory-based RP PCR testing +/- atypical serology on odd days (control). The primary outcome was length of hospital stay. The secondary outcomes were impact on the use of antimicrobials, readmissions, all-cause mortality, length of ward stay and turn-around time (TAT) (time to result from admission).
Of 606 eligible patients, 545 (89.9%) were included; 211 in the control arm and 334 in the intervention arm. 20% of control arm patients and 24% of intervention arm patients had an RP detected. POC testing was not associated with the primary outcome measure, length of stay, but reduced the TAT from 39.5 h to 19.0 h, p < 0.001. Only the prescribing decision differed between study arms, p < 0.001. When antivirals were given, the intervention was associated with a reduction in the median time to the first dose of 36 h and allowed appropriate treatment of mycoplasma infection.
We found no association between respiratory PCR POC testing and length of stay or most of the secondary outcomes except the antimicrobial prescribing decision. This was probably due to a delay in initiating FilmArray® testing. Despite this, POC testing allowed time-critical antivirals to be given significantly faster, appropriate mycoplasma treatment and results were available considerably faster than routine, laboratory-based testing. Ward-staff of all grades performed POC testing without difficulty suggesting potential use across many divergent healthcare settings. Further studies evaluating the implementation of rapid respiratory PCR POC testing and the effect on length of stay and antimicrobial use are required.
ISRCTN10470967 , Retrospectively Registered, 30/6/2015.</description><subject>Adults</subject><subject>Aged</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Bacterial infections</subject><subject>Chlamydia</subject><subject>Chlamydia pneumoniae</subject><subject>Clinical outcomes</subject><subject>Emergency medical care</subject><subject>Epidemics</subject><subject>Female</subject><subject>FilmArray</subject><subject>Holidays & special occasions</subject><subject>Hospital costs</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Illnesses</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Influenza</subject><subject>Influenza, Human - genetics</subject><subject>Length of stay</subject><subject>Length of Stay - statistics & numerical data</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multiplex Polymerase Chain Reaction - methods</subject><subject>Multiplexing</subject><subject>Mycoplasma pneumoniae</subject><subject>Patients</subject><subject>Pneumonia</subject><subject>Point of care</subject><subject>Point-of-Care Testing - statistics & numerical data</subject><subject>Point-of-Care Testing - utilization</subject><subject>Respiratory pathogens</subject><subject>Respiratory syncytial virus</subject><subject>Respiratory tract</subject><subject>Respiratory tract diseases</subject><subject>Respiratory tract infection</subject><subject>Respiratory Tract Infections - drug therapy</subject><subject>Respiratory Tract Infections - microbiology</subject><subject>Respiratory viruses</subject><subject>Retrospective Studies</subject><subject>Testing laboratories</subject><subject>Viruses</subject><issn>1471-2334</issn><issn>1471-2334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdks1u1TAQhSMEoqXwAGyQJTYsCMTOn8OiErrip1IRCMHamsTje10lcWo7hdtn5WGYNOWqRZEVOznnG3t8kuQ5z95wLqu3gQtZN2nG61TUskivHyTHvKh5KvK8eHhnfpQ8CeEiI6EUzePkSDQ0LUp-nPz5MvfRTj3-Zt8239nk7BiZM6wDjyxiiHbcsiv0YQ7Mu5mW-Jr10DoP0fl92kJAfRDakcUd-TxCHHAlgaYKgf2yccc8hsmuThJBF8lhsIvWjeEdA3Y5Q7Cph1G7wS7gEGe9ZxAChnBTYJgWlxtZj-OWiFQgRCDJqGlEO9jOu9ZCz-aAT5NHBvqAz27fJ8nPjx9-bD6n518_nW3en6dd0eQxrfOsNlXRCl00GjOsDNIjuioTWQtZIWWjBZi6FE0uuWi41lqYzIhGc6FNkZ8kZytXO7hQk7cD-L1yYNXNB-e3Cny0XY-qlHnJsQIpc1Nw6BppJHYNYFbVUvKWWKcra5rbAXVHXfTQ34Pe_zPandq6K1VWeUnHIcCrW4B3lzNdjKJWdtj3MKKbg-JNuVx-xQVJX_4nvXCzH6lVi0qWNWWnJBVfVdTZEDyaw2Z4ppYcqjWHirBqyaG6Js-Lu6c4OP4FL_8L-dDgIg</recordid><startdate>20171010</startdate><enddate>20171010</enddate><creator>Andrews, Denise</creator><creator>Chetty, Yumela</creator><creator>Cooper, Ben S</creator><creator>Virk, Manjinder</creator><creator>Glass, Stephen K</creator><creator>Letters, Andrew</creator><creator>Kelly, Philip A</creator><creator>Sudhanva, Malur</creator><creator>Jeyaratnam, Dakshika</creator><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T2</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20171010</creationdate><title>Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use</title><author>Andrews, Denise ; Chetty, Yumela ; Cooper, Ben S ; Virk, Manjinder ; Glass, Stephen K ; Letters, Andrew ; Kelly, Philip A ; Sudhanva, Malur ; Jeyaratnam, Dakshika</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-7307f64b2d49de0e6fefef2c6020ba04889d2af7529381291ddd2f0f29d12df43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adults</topic><topic>Aged</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Bacterial infections</topic><topic>Chlamydia</topic><topic>Chlamydia pneumoniae</topic><topic>Clinical outcomes</topic><topic>Emergency medical care</topic><topic>Epidemics</topic><topic>Female</topic><topic>FilmArray</topic><topic>Holidays & special occasions</topic><topic>Hospital costs</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Illnesses</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Influenza</topic><topic>Influenza, Human - genetics</topic><topic>Length of stay</topic><topic>Length of Stay - statistics & numerical data</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multiplex Polymerase Chain Reaction - methods</topic><topic>Multiplexing</topic><topic>Mycoplasma pneumoniae</topic><topic>Patients</topic><topic>Pneumonia</topic><topic>Point of care</topic><topic>Point-of-Care Testing - statistics & numerical data</topic><topic>Point-of-Care Testing - utilization</topic><topic>Respiratory pathogens</topic><topic>Respiratory syncytial virus</topic><topic>Respiratory tract</topic><topic>Respiratory tract diseases</topic><topic>Respiratory tract infection</topic><topic>Respiratory Tract Infections - drug therapy</topic><topic>Respiratory Tract Infections - microbiology</topic><topic>Respiratory viruses</topic><topic>Retrospective Studies</topic><topic>Testing laboratories</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Andrews, Denise</creatorcontrib><creatorcontrib>Chetty, Yumela</creatorcontrib><creatorcontrib>Cooper, Ben S</creatorcontrib><creatorcontrib>Virk, Manjinder</creatorcontrib><creatorcontrib>Glass, Stephen K</creatorcontrib><creatorcontrib>Letters, Andrew</creatorcontrib><creatorcontrib>Kelly, Philip A</creatorcontrib><creatorcontrib>Sudhanva, Malur</creatorcontrib><creatorcontrib>Jeyaratnam, Dakshika</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database (Proquest)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMC infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Andrews, Denise</au><au>Chetty, Yumela</au><au>Cooper, Ben S</au><au>Virk, Manjinder</au><au>Glass, Stephen K</au><au>Letters, Andrew</au><au>Kelly, Philip A</au><au>Sudhanva, Malur</au><au>Jeyaratnam, Dakshika</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use</atitle><jtitle>BMC infectious diseases</jtitle><addtitle>BMC Infect Dis</addtitle><date>2017-10-10</date><risdate>2017</risdate><volume>17</volume><issue>1</issue><spage>671</spage><epage>671</epage><pages>671-671</pages><artnum>671</artnum><issn>1471-2334</issn><eissn>1471-2334</eissn><abstract>Laboratory-based respiratory pathogen (RP) results are often available too late to influence clinical decisions such as hospitalisation or antibiotic treatment due to time delay in transport of specimens and testing schedules. Ward-based i.e. point of care (POC) testing providing rapid results may alter the clinical management pathway.
FilmArray® RP polymerase chain reaction (PCR) systems were placed in three in-patient and out-patient medical areas. Patients presenting with influenza-like illness /upper respiratory tract infection +/- lower RTI were recruited between January-July 2015. FilmArray® POC testing occurred on even days of the month (intervention) or routine, laboratory-based RP PCR testing +/- atypical serology on odd days (control). The primary outcome was length of hospital stay. The secondary outcomes were impact on the use of antimicrobials, readmissions, all-cause mortality, length of ward stay and turn-around time (TAT) (time to result from admission).
Of 606 eligible patients, 545 (89.9%) were included; 211 in the control arm and 334 in the intervention arm. 20% of control arm patients and 24% of intervention arm patients had an RP detected. POC testing was not associated with the primary outcome measure, length of stay, but reduced the TAT from 39.5 h to 19.0 h, p < 0.001. Only the prescribing decision differed between study arms, p < 0.001. When antivirals were given, the intervention was associated with a reduction in the median time to the first dose of 36 h and allowed appropriate treatment of mycoplasma infection.
We found no association between respiratory PCR POC testing and length of stay or most of the secondary outcomes except the antimicrobial prescribing decision. This was probably due to a delay in initiating FilmArray® testing. Despite this, POC testing allowed time-critical antivirals to be given significantly faster, appropriate mycoplasma treatment and results were available considerably faster than routine, laboratory-based testing. Ward-staff of all grades performed POC testing without difficulty suggesting potential use across many divergent healthcare settings. Further studies evaluating the implementation of rapid respiratory PCR POC testing and the effect on length of stay and antimicrobial use are required.
ISRCTN10470967 , Retrospectively Registered, 30/6/2015.</abstract><cop>England</cop><pub>BioMed Central</pub><pmid>29017451</pmid><doi>10.1186/s12879-017-2784-z</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1471-2334 |
ispartof | BMC infectious diseases, 2017-10, Vol.17 (1), p.671-671, Article 671 |
issn | 1471-2334 1471-2334 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_58351e6a883f41ac98f8ec9ae067881b |
source | Publicly Available Content Database; PubMed Central; Coronavirus Research Database |
subjects | Adults Aged Anti-Infective Agents - therapeutic use Antibiotics Antimicrobial agents Bacterial infections Chlamydia Chlamydia pneumoniae Clinical outcomes Emergency medical care Epidemics Female FilmArray Holidays & special occasions Hospital costs Hospitalization Humans Illnesses Infections Infectious diseases Influenza Influenza, Human - genetics Length of stay Length of Stay - statistics & numerical data Male Middle Aged Multiplex Polymerase Chain Reaction - methods Multiplexing Mycoplasma pneumoniae Patients Pneumonia Point of care Point-of-Care Testing - statistics & numerical data Point-of-Care Testing - utilization Respiratory pathogens Respiratory syncytial virus Respiratory tract Respiratory tract diseases Respiratory tract infection Respiratory Tract Infections - drug therapy Respiratory Tract Infections - microbiology Respiratory viruses Retrospective Studies Testing laboratories Viruses |
title | Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T20%3A03%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiplex%20PCR%20point%20of%20care%20testing%20versus%20routine,%20laboratory-based%20testing%20in%20the%20treatment%20of%20adults%20with%20respiratory%20tract%20infections:%20a%20quasi-randomised%20study%20assessing%20impact%20on%20length%20of%20stay%20and%20antimicrobial%20use&rft.jtitle=BMC%20infectious%20diseases&rft.au=Andrews,%20Denise&rft.date=2017-10-10&rft.volume=17&rft.issue=1&rft.spage=671&rft.epage=671&rft.pages=671-671&rft.artnum=671&rft.issn=1471-2334&rft.eissn=1471-2334&rft_id=info:doi/10.1186/s12879-017-2784-z&rft_dat=%3Cproquest_doaj_%3E1950174612%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c493t-7307f64b2d49de0e6fefef2c6020ba04889d2af7529381291ddd2f0f29d12df43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1958572335&rft_id=info:pmid/29017451&rfr_iscdi=true |